Ratings by UBS (Douglas Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Veracyte, Inc | VCYT | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2026 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
64.29 (61.45) |
-4.42% | Details | |
| 9/9/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
324.14 (328.55) |
1.36% | Details | |
| 9/9/2026 | Myriad Genetics | MYGN | New Coverage | Neutral (N/A) |
3.18 (3.19) |
0.31% | Details | |
| 9/9/2026 | HeartFlow | HTFL | New Coverage | Neutral (N/A) |
47.75 (47.10) |
-1.36% | Details | |
| 9/9/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
160.98 (164.39) |
2.12% | Details | |
| 9/9/2026 | GRAIL, Inc. | GRAL | New Coverage | Buy (N/A) |
79.10 (77.39) |
-2.16% | Details | |
| 9/9/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
24.82 (24.38) |
-1.77% | Details | |
| 9/9/2026 | West Pharmaceutical | WST | New Coverage | Buy (N/A) |
337.75 (338.40) |
0.19% | Details | |
| 9/9/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Neutral (N/A) |
20.32 (20.24) |
-0.39% | Details | |
| 9/9/2026 | Twist Bioscience | TWST | New Coverage | Neutral (N/A) |
128.06 (126.08) |
-1.55% | Details | |
| 9/9/2026 | Pacific Biosciences of California | PACB | New Coverage | Neutral (N/A) |
1.32 (1.29) |
-2.27% | Details | |
| 9/9/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
65.60 (66.56) |
1.46% | Details | |
| 9/9/2026 | Repligen | RGEN | New Coverage | Buy (N/A) |
168.53 (165.52) |
-1.79% | Details | |
| 9/9/2026 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Neutral (N/A) |
|
Details | ||
| 9/9/2026 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
127.08 (124.20) |
-2.27% | Details | |
| 9/9/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
42.38 (42.37) |
-0.02% | Details | |
| 9/9/2026 | Waters Corp. | WAT | New Coverage | Buy (N/A) |
402.91 (408.10) |
1.29% | Details | |
| 9/9/2026 | Mettler-Toledo | MTD | New Coverage | Neutral (N/A) |
1325.52 (1295.98) |
-2.23% | Details | |
| 9/9/2026 | Illumina | ILMN | New Coverage | Buy (N/A) |
211.06 (206.25) |
-2.28% | Details | |
| 9/9/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
58.37 (54.48) |
-6.66% | Details | |
| 9/9/2026 | Avantor Inc. | AVTR | New Coverage | Neutral (N/A) |
15.25 (14.88) |
-2.43% | Details | |
| 9/9/2026 | Agilent | A | New Coverage | Neutral (N/A) |
146.85 (145.35) |
-1.02% | Details | |
| 9/9/2026 | Thermo Fisher Scientific | TMO | Upgrade | Buy (Neutral) |
613.78 (605.57) |
-1.34% | Details | |
| 9/9/2026 | Danaher | DHR | New Coverage | Buy (N/A) |
207.66 (204.63) |
-1.46% | Details |
